This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. The Food and Drug Administration on Monday approved a ...
Pharmaceutical Technology on MSN
RNA-targeting small molecules: A new frontier of drug discovery
With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology ...
LYNCHBURG — For about two and a half years, Tarrah and Patrick Osmulski lived their life knowing their daughter had a life expectancy of only a few years. Their nearly 4-year-old daughter, Kennedy, ...
Nov 25 (Reuters) - Biohaven (BHVN.N), opens new tab said on Monday its experimental treatment for a rare neuromuscular disorder failed to significantly improve motor function in a late-stage trial, ...
Biogen BIIB announced that the FDA has issued a complete response letter (CRL) to its supplemental new drug application (sNDA) seeking label expansion for a higher dose of its renowned spinal muscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results